CEO is indeed head down bum up managing the RePosa stageII OSA 42X underway
'Phase 2 of the RePOSA study will be conducted at 25 sites in the United States. Phase 3 will extend the study to 30 additional sites across the EU and UK.'
30 million osa sufferers across the US alone - only 6 million diagnosed within that cohort - not really much of a market ..
